Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Halozyme Therapeutics
ClinicalTrials.gov Identifier:
NCT01170897
First received: July 26, 2010
Last updated: January 27, 2014
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)